Cost Effectiveness Working Group - REG - Respiratory Effectiveness Group

Work Plan

When considering treatment, it is important to not only assess the clinical efficacy of a treatment for a patient but also the cost of a treatment to ensure it is cost-effective. The Cost Effectiveness Working Group conduct studies to assess the cost-effectiveness of respiratory treatments, raise awareness of cost-effectiveness and provide input for clinical studies with an economic component.

Minutes from recent REG Cost Effectiveness working group meetings

REG Summit, March 2023

ERS, September 2022

REG Summit, March 2022

REG Summit, March 2018

ERS, September 2017